Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 137

1.

Identifying the Key Risk Factors for Adverse Psychological Outcomes Among Police Officers A Systematic Literature Review.

Sherwood L, Hegarty S, Vallières F, Hyland P, Murphy J, Fitzgerald G, Reid T.

J Trauma Stress. 2019 Sep 25. doi: 10.1002/jts.22431. [Epub ahead of print]

PMID:
31553502
2.

Mortality and Hospitalization Risk Following Oral Androgen Signaling Inhibitors Among Men with Advanced Prostate Cancer by Pre-existing Cardiovascular Comorbidities.

Lu-Yao G, Nikita N, Keith SW, Nightingale G, Gandhi K, Hegarty SE, Rebbeck TR, Chapman A, Kantoff PW, Cullen J, Gomella L, Kelly WK.

Eur Urol. 2019 Aug 2. pii: S0302-2838(19)30585-8. doi: 10.1016/j.eururo.2019.07.031. [Epub ahead of print]

PMID:
31420248
3.

Prevalence of Suspected Hereditary Cancer Syndromes and Germline Mutations Among a Diverse Cohort of Probands Reporting a Family History of Prostate Cancer: Toward Informing Cascade Testing for Men.

Chandrasekar T, Gross L, Gomella LG, Hegarty SE, Leong JY, Giri VN.

Eur Urol Oncol. 2019 Jul 2. pii: S2588-9311(19)30085-9. doi: 10.1016/j.euo.2019.06.010. [Epub ahead of print]

PMID:
31278035
4.

Evaluation of Care Processes and Health Care Utilization in Newly Implemented Medical Homes in Italy: A Population-Based Cross-sectional Study.

Alcusky M, Singer D, Keith SW, Hegarty SE, Lombardi M, Saccenti E, Maio V.

Am J Med Qual. 2019 Jul 4:1062860619860590. doi: 10.1177/1062860619860590. [Epub ahead of print]

PMID:
31271037
5.

Awareness of ocular diagnosis, transportation means, and barriers to ophthalmology follow-up in the Philadelphia Telemedicine Glaucoma Detection and Follow-up Study.

Hark LA, Radakrishnan A, Madhava M, Anderson-Quiñones C, Fudemberg S, Robinson D, Myers JS, Zhan T, Adeghate J, Hegarty S, Leite S, Leiby BE, Stempel S, Katz LJ.

Soc Work Health Care. 2019 Aug;58(7):651-664. doi: 10.1080/00981389.2019.1614711. Epub 2019 May 23.

PMID:
31120381
6.

Frequency modulated hybrid photonic crystal laser by thermal tuning.

Butler SM, Bakoz AP, Singaravelu PKJ, Liles AA, O'Shaughnessy B, Viktorov EA, O'Faolain L, Hegarty SP.

Opt Express. 2019 Apr 15;27(8):11312-11322. doi: 10.1364/OE.27.011312.

PMID:
31052977
7.

Philadelphia Telemedicine Glaucoma Detection and Follow-up Study: Intraocular Pressure Measurements Found in a Population at High Risk for Glaucoma.

Hark LA, Myers JS, Pasquale LR, Razeghinejad MR, Maity A, Zhan T, Hegarty SE, Leiby BE, Waisbourd M, Burns C, Divers M, Molineaux J, Henderer JD, Haller JA, Katz LJ.

J Glaucoma. 2019 Apr;28(4):294-301. doi: 10.1097/IJG.0000000000001207.

PMID:
30946709
8.

Quantitative sensory testing in children with sickle cell disease: additional insights and future possibilities.

Miller RE, Brown DS, Keith SW, Hegarty SE, Setty Y, Campbell CM, McCahan SM, Gayen-Betal S, Byck H, Stuart M.

Br J Haematol. 2019 Jun;185(5):925-934. doi: 10.1111/bjh.15876. Epub 2019 Mar 28.

9.

Experimental electric field visualisation of multi-mode dynamics in a short cavity swept laser designed for OCT applications.

Butler TP, Goulding D, Slepneva S, O'Shaughnessy B, Hegarty SP, Huyet G, Kelleher B.

Opt Express. 2019 Mar 4;27(5):7307-7318. doi: 10.1364/OE.27.007307.

PMID:
30876296
10.

Treatment plan consistency with guidelines for older adults with cancer.

MacKenzie AR, Barsevick AM, Myers R, Hegarty SE, Keith SW, Patel S, Lapinsky E, Schoppe J, Williams U 3rd, Chapman AE.

J Geriatr Oncol. 2019 Sep;10(5):832-834. doi: 10.1016/j.jgo.2019.01.022. Epub 2019 Mar 6. No abstract available.

PMID:
30852179
11.

Wavelength stability in a hybrid photonic crystal laser through controlled nonlinear absorptive heating in the reflector.

Bakoz AP, Liles AA, Gonzalez-Fernandez AA, Habruseva T, Hu C, Viktorov EA, Hegarty SP, O'Faolain L.

Light Sci Appl. 2018 Jul 25;7:39. doi: 10.1038/s41377-018-0043-8. eCollection 2018.

12.

Philadelphia Telemedicine Glaucoma Detection and Follow-up Study: confirmation between eye screening and comprehensive eye examination diagnoses.

Hark LA, Myers JS, Ines A, Jiang A, Rahmatnejad K, Zhan T, Leiby BE, Hegarty S, Fudemberg SJ, Mantravadi AV, Waisbourd M, Henderer JD, Burns C, Divers M, Molineaux J, Pizzi LT, Murchison AP, Saaddine J, Pasquale LR, Haller JA, Katz LJ.

Br J Ophthalmol. 2019 Feb 15. pii: bjophthalmol-2018-313451. doi: 10.1136/bjophthalmol-2018-313451. [Epub ahead of print]

PMID:
30770354
13.

Mid-infrared optical sensing using sub-wavelength gratings.

Hogan B, Lewis L, McAuliffe M, Hegarty SP.

Opt Express. 2019 Feb 4;27(3):3169-3179. doi: 10.1364/OE.27.003169.

PMID:
30732342
14.

Germline genetic testing for inherited prostate cancer in practice: Implications for genetic testing, precision therapy, and cascade testing.

Giri VN, Hegarty SE, Hyatt C, O'Leary E, Garcia J, Knudsen KE, Kelly WK, Gomella LG.

Prostate. 2019 Mar;79(4):333-339. doi: 10.1002/pros.23739. Epub 2018 Nov 18.

PMID:
30450585
15.

Decision Support and Navigation to Increase Colorectal Cancer Screening Among Hispanic Patients.

Myers RE, Stello B, Daskalakis C, Sifri R, González ET, DiCarlo M, Johnson MB, Hegarty SE, Shaak K, Rivera A, Gordils-Molina L, Petrich A, Careyva B, de-Ortiz R, Diaz L.

Cancer Epidemiol Biomarkers Prev. 2019 Feb;28(2):384-391. doi: 10.1158/1055-9965.EPI-18-0260. Epub 2018 Oct 17.

PMID:
30333221
16.

Reactivation of Dormant Relay Pathways in Injured Spinal Cord by KCC2 Manipulations.

Chen B, Li Y, Yu B, Zhang Z, Brommer B, Williams PR, Liu Y, Hegarty SV, Zhou S, Zhu J, Guo H, Lu Y, Zhang Y, Gu X, He Z.

Cell. 2018 Sep 6;174(6):1599. doi: 10.1016/j.cell.2018.08.050. No abstract available.

17.

Philadelphia Telemedicine Glaucoma Detection and Follow-up Study: Analysis of Unreadable Fundus Images.

Hark LA, Myers JS, Rahmatnejad K, Wang Q, Zhan T, Hegarty SE, Leiby BE, Udyaver S, Waisbourd M, Leite S, Henderer JD, Pasquale LR, Lee PP, Haller JA, Katz LJ.

J Glaucoma. 2018 Nov;27(11):999-1008. doi: 10.1097/IJG.0000000000001082.

PMID:
30180021
18.

Thermally stable hybrid cavity laser based on silicon nitride gratings.

Iadanza S, Bakoz AP, Singaravelu PKJ, Panettieri D, Schulz SA, Devarapu GCR, Guerber S, Baudot C, Boeuf F, Hegarty S, O'Faolain L.

Appl Opt. 2018 Aug 1;57(22):E218-E223. doi: 10.1364/AO.57.00E218.

PMID:
30117905
19.

Reactivation of Dormant Relay Pathways in Injured Spinal Cord by KCC2 Manipulations.

Chen B, Li Y, Yu B, Zhang Z, Brommer B, Williams PR, Liu Y, Hegarty SV, Zhou S, Zhu J, Guo H, Lu Y, Zhang Y, Gu X, He Z.

Cell. 2018 Jul 26;174(3):521-535.e13. doi: 10.1016/j.cell.2018.06.005. Epub 2018 Jul 19. Erratum in: Cell. 2018 Sep 6;174(6):1599.

20.

Effectiveness of palliative care services: A population-based study of end-of-life care for cancer patients.

De Palma R, Fortuna D, Hegarty SE, Louis DZ, Melotti RM, Moro ML.

Palliat Med. 2018 Sep;32(8):1344-1352. doi: 10.1177/0269216318778729. Epub 2018 Jun 11.

PMID:
29886795
21.

Resonant gratings with an etch-stop layer and a fabrication-error tolerant design.

Hogan B, Lewis L, Romero-Vivas J, Ochalski TJ, Hegarty SP.

Opt Express. 2018 May 14;26(10):13205-13213. doi: 10.1364/OE.26.013205.

PMID:
29801347
22.

How confident are physicians in deprescribing for the elderly and what barriers prevent deprescribing?

Djatche L, Lee S, Singer D, Hegarty SE, Lombardi M, Maio V.

J Clin Pharm Ther. 2018 Aug;43(4):550-555. doi: 10.1111/jcpt.12688. Epub 2018 Apr 22.

PMID:
29682764
23.

Understanding of multigene test results among males undergoing germline testing for inherited prostate cancer: Implications for genetic counseling.

Giri VN, Obeid E, Hegarty SE, Gross L, Bealin L, Hyatt C, Fang CY, Leader A.

Prostate. 2018 Sep;78(12):879-888. doi: 10.1002/pros.23535. Epub 2018 Apr 14.

24.

Targeting transcriptional regulators to regenerate midbrain dopaminergic axons in Parkinson's disease.

Hegarty SV, Sullivan AM, O'Keeffe GW.

Neural Regen Res. 2017 Nov;12(11):1814-1815. doi: 10.4103/1673-5374.219039. No abstract available.

25.

Direct experimental measurement of single-mode and mode-hopping dynamics in frequency swept lasers.

Butler TP, Goulding D, Kelleher B, O'Shaughnessy B, Slepneva S, Hegarty SP, Huyet G.

Opt Express. 2017 Oct 30;25(22):27464-27474. doi: 10.1364/OE.25.027464.

PMID:
29092219
26.

Exposure to Hypertensive Disorders of Pregnancy Increases the Risk of Autism Spectrum Disorder in Affected Offspring.

Curran EA, O'Keeffe GW, Looney AM, Moloney G, Hegarty SV, Murray DM, Khashan AS, Kenny LC.

Mol Neurobiol. 2018 Jul;55(7):5557-5564. doi: 10.1007/s12035-017-0794-x. Epub 2017 Oct 3.

PMID:
28975539
27.

Zeb2 is a negative regulator of midbrain dopaminergic axon growth and target innervation.

Hegarty SV, Wyatt SL, Howard L, Stappers E, Huylebroeck D, Sullivan AM, O'Keeffe GW.

Sci Rep. 2017 Aug 17;7(1):8568. doi: 10.1038/s41598-017-08900-3.

28.

Hospitalization rates during potentially inappropriate medication use in a large population-based cohort of older adults.

Varga S, Alcusky M, Keith SW, Hegarty SE, Del Canale S, Lombardi M, Maio V.

Br J Clin Pharmacol. 2017 Nov;83(11):2572-2580. doi: 10.1111/bcp.13365. Epub 2017 Aug 4.

29.

Romidepsin induces caspase-dependent cell death in human neuroblastoma cells.

Hegarty SV, Togher KL, O'Leary E, Solger F, Sullivan AM, O'Keeffe GW.

Neurosci Lett. 2017 Jul 13;653:12-18. doi: 10.1016/j.neulet.2017.05.025. Epub 2017 May 12.

PMID:
28506690
30.

Repeat application of microneedles does not alter skin appearance or barrier function and causes no measurable disturbance of serum biomarkers of infection, inflammation or immunity in mice in vivo.

Vicente-Perez EM, Larrañeta E, McCrudden MTC, Kissenpfennig A, Hegarty S, McCarthy HO, Donnelly RF.

Eur J Pharm Biopharm. 2017 Aug;117:400-407. doi: 10.1016/j.ejpb.2017.04.029. Epub 2017 May 3.

31.

Effects of intracerebral neurotrophic factor application on motor symptoms in Parkinson's disease: A systematic review and meta-analysis.

Hegarty SV, Lee DJ, O'Keeffe GW, Sullivan AM.

Parkinsonism Relat Disord. 2017 May;38:19-25. doi: 10.1016/j.parkreldis.2017.02.011. Epub 2017 Feb 10. Review.

PMID:
28215730
32.

Endocytosis contributes to BMP2-induced Smad signalling and neuronal growth.

Hegarty SV, Sullivan AM, O'Keeffe GW.

Neurosci Lett. 2017 Mar 16;643:32-37. doi: 10.1016/j.neulet.2017.02.013. Epub 2017 Feb 8.

PMID:
28188849
33.

The Epigenome as a therapeutic target for Parkinson's disease.

Hegarty SV, Sullivan AM, O'Keeffe GW.

Neural Regen Res. 2016 Nov;11(11):1735-1738. doi: 10.4103/1673-5374.194803. Review.

34.

Prevalence and Characteristics of Patients with Suspected Inherited Renal Cell Cancer: Application of the ACMG/NSGC Genetic Referral Guidelines to Patient Cohorts.

Truong H, Hegarty SE, Gomella LG, Kelly WK, Trabulsi EJ, Lallas CD, Giri VN.

J Genet Couns. 2017 Jun;26(3):548-555. doi: 10.1007/s10897-016-0020-4. Epub 2017 Jan 19.

PMID:
28101821
35.

A Comparative Study of the Water Drinking Test in Eyes With Open-Angle Glaucoma and Prior Trabeculectomy or Tube Shunt.

Martinez P, Trubnik V, Leiby BE, Hegarty SE, Razeghinejad R, Savant S, Myers JS.

J Glaucoma. 2017 Feb;26(2):119-125. doi: 10.1097/IJG.0000000000000589.

PMID:
27875485
36.

Realization of high-contrast gratings operating at 10  μm.

Hogan B, Hegarty SP, Lewis L, Romero-Vivas J, Ochalski TJ, Huyet G.

Opt Lett. 2016 Nov 1;41(21):5130-5133. doi: 10.1364/OL.41.005130.

PMID:
27805701
37.

Variation in hospital utilization at the end of life for patients with cancer in the Emilia-Romagna region of Italy.

Louis DZ, Hegarty SE, Leoni M, De Palma R, Varga S, Melotti R.

Tumori. 2016 Dec 1;102(6):614-620. doi: 10.5301/tj.5000544. Epub 2016 Aug 5.

PMID:
27514312
38.

Post-treatment problems of African American breast cancer survivors.

Barsevick AM, Leader A, Bradley PK, Avery T, Dean LT, DiCarlo M, Hegarty SE.

Support Care Cancer. 2016 Dec;24(12):4979-4986. Epub 2016 Aug 19.

39.
40.

Injection-induced, tunable all-optical gating in a two-state quantum dot laser.

Viktorov EA, Dubinkin I, Fedorov N, Erneux T, Tykalewicz B, Hegarty SP, Huyet G, Goulding D, Kelleher B.

Opt Lett. 2016 Aug 1;41(15):3555-8. doi: 10.1364/OL.41.003555.

PMID:
27472617
41.

Protocol for evaluation of neurotrophic strategies in Parkinson's disease-related dopaminergic and sympathetic neurons in vitro.

Hegarty SV, Sullivan AM, O'Keeffe GW.

J Biol Methods. 2016 Jul 25;3(3):e50. doi: 10.14440/jbm.2016.124. eCollection 2016.

42.

Decision Support and Shared Decision Making About Active Surveillance Versus Active Treatment Among Men Diagnosed with Low-Risk Prostate Cancer: a Pilot Study.

Myers RE, Leader AE, Censits JH, Trabulsi EJ, Keith SW, Petrich AM, Quinn AM, Den RB, Hurwitz MD, Lallas CD, Hegarty SE, Dicker AP, Zeigler-Johnson CM, Giri VN, Ayaz H, Gomella LG.

J Cancer Educ. 2018 Feb;33(1):180-185. doi: 10.1007/s13187-016-1073-7.

PMID:
27418065
43.

A Small Molecule Activator of p300/CBP Histone Acetyltransferase Promotes Survival and Neurite Growth in a Cellular Model of Parkinson's Disease.

Hegarty SV, O'Leary E, Solger F, Stanicka J, Sullivan AM, O'Keeffe GW.

Neurotox Res. 2016 Oct;30(3):510-20. doi: 10.1007/s12640-016-9636-2. Epub 2016 Jun 2.

PMID:
27256286
44.

Optically induced hysteresis in a two-state quantum dot laser.

Tykalewicz B, Goulding D, Hegarty SP, Huyet G, Dubinkin I, Fedorov N, Erneux T, Viktorov EA, Kelleher B.

Opt Lett. 2016 Mar 1;41(5):1034-7. doi: 10.1364/OL.41.001034.

PMID:
26974109
45.

Emergence of resonant mode-locking via delayed feedback in quantum dot semiconductor lasers.

Tykalewicz B, Goulding D, Hegarty SP, Huyet G, Erneux T, Kelleher B, Viktorov EA.

Opt Express. 2016 Feb 22;24(4):4239-46.

PMID:
26907071
46.

Attitudes towards physician-nurse collaboration in a primary care team-based setting: Survey-based research conducted in the chronic care units of the Tuscany region of Italy.

Vegesna A, Coschignano C, Hegarty SE, Karagiannis T, Polenzani L, Messina E, Zoli R, Maio V.

J Interprof Care. 2016;30(1):65-70. doi: 10.3109/13561820.2015.1081878.

PMID:
26833107
47.

Optical ultrafast random number generation at 1 Tb/s using a turbulent semiconductor ring cavity laser.

Butler T, Durkan C, Goulding D, Slepneva S, Kelleher B, Hegarty SP, Huyet G.

Opt Lett. 2016 Jan 15;41(2):388-91. doi: 10.1364/OL.41.000388.

PMID:
26766721
48.

Postoperative Chemoradiation Therapy in High-Risk Cervical Cancer: Re-evaluating the Findings of Gynecologic Oncology Group Study 109 in a Large, Population-Based Cohort.

Trifiletti DM, Swisher-McClure S, Showalter TN, Hegarty SE, Grover S.

Int J Radiat Oncol Biol Phys. 2015 Dec 1;93(5):1032-44. doi: 10.1016/j.ijrobp.2015.09.001. Epub 2015 Sep 11.

PMID:
26581141
49.

Relationships Between Measures of the Ability to Perform Vision-Related Activities, Vision-Related Quality of Life, and Clinical Findings in Patients With Glaucoma.

Ekici F, Loh R, Waisbourd M, Sun Y, Martinez P, Nayak N, Wizov SS, Hegarty S, Hark LA, Spaeth GL.

JAMA Ophthalmol. 2015 Dec;133(12):1377-85. doi: 10.1001/jamaophthalmol.2015.3426.

PMID:
26425961
50.

Single shot, time-resolved measurement of the coherence properties of OCT swept source lasers.

Butler T, Slepneva S, O'Shaughnessy B, Kelleher B, Goulding D, Hegarty SP, Lyu HC, Karnowski K, Wojtkowski M, Huyet G.

Opt Lett. 2015 May 15;40(10):2277-80. doi: 10.1364/OL.40.002277.

PMID:
26393718

Supplemental Content

Loading ...
Support Center